Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Spectrophotometric Determination of Serum Copper with Biscyclohexanoneoxalyldihydrazone
MS clinical trials: what can subgroup analyses teach us?
Pregnancy and multiple sclerosis.
SJL mice exposed to cuprizone intoxication reveal strain and gender pattern differences in demyelination.
HLA-DRB1*1501 tagging rs3135388 polymorphism is not associated with neuromyelitis optica.
Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis.
Extracellular Cues Influencing Oligodendrocyte Differentiation and (Re)myelination.
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial.
TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination.
Long-term efficacy and safety of transanal irrigation in multiple sclerosis.
Oral BG-12 (dimethyl fumarate) significantly reduced multiple sclerosis (MS) relapses and disability progression in DEFINE Phase 3 clinical trial
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.
Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the DEFINE study.
A New Colour Reaction on Copper and Certain Carbonyl Compounds
Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study.
Masitinib mesylate application for conditional approval
MRI identification of the rostral-caudal pattern of pathology within the corpus callosum in the cuprizone mouse model.
Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?
GlaxoSmithKline Product Development Pipeline
Delayed visual evoked response in optic neuritis.
Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study.
In vitro and in vivo pharmacological models to assess demyelination and remyelination.
Neuroprotective dimethyl fumarate synergizes with immunomodulatory interferon beta to provide enhanced axon protection in autoimmune neuroinflammation.
Comparative efficacy of interferon β versus glatiramer acetate for relapsing-remitting multiple sclerosis.
Meta-analysis of adverse events in recent randomized clinical trials for dimethil fumarate, glatiramer acetate and teriflunomide for the treatment of relapsing forms of multiple sclerosis.

Pages